DCUN1D1 Antibody (monoclonal) (M01)
Mouse monoclonal antibody raised against a partial recombinant DCUN1D1.
|Application ||WB, IF|
|Reactivity||Human, Mouse, Rat|
|Calculated MW||30124 Da|
|Other Names||DCN1-like protein 1, DCUN1 domain-containing protein 1, Defective in cullin neddylation protein 1-like protein 1, Squamous cell carcinoma-related oncogene, DCUN1D1, DCUN1L1, RP42, SCCRO|
|Target/Specificity||DCUN1D1 (NP_065691, 1 a.a. ~ 89 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.|
|Format||Clear, colorless solution in phosphate buffered saline, pH 7.2 .|
|Storage||Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.|
|Precautions||DCUN1D1 Antibody (monoclonal) (M01) is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
DCUN1D1 is a risk factor for frontotemporal lobar degeneration. Villa C, et al. Eur J Neurol, 2009 Jul. PMID 19473369.SCCRO (DCUN1D1) induces extracellular matrix invasion by activating matrix metalloproteinase 2. O-charoenrat P, et al. Clin Cancer Res, 2008 Nov 1. PMID 18980971.SCCRO (DCUN1D1) is an essential component of the E3 complex for neddylation. Kim AY, et al. J Biol Chem, 2008 Nov 28. PMID 18826954.Squamous cell carcinoma related oncogene/DCUN1D1 is highly conserved and activated by amplification in squamous cell carcinomas. Sarkaria I, et al. Cancer Res, 2006 Oct 1. PMID 17018598.Towards a proteome-scale map of the human protein-protein interaction network. Rual JF, et al. Nature, 2005 Oct 20. PMID 16189514.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.